F-10POS: Oncolytics Biotech Deregisters Unsold Securities
Securities Deregistration
Oncolytics Biotech Inc. has filed post-effective amendments to withdraw multiple Form F-10 registration statements, deregistering unsold securities.
Summary
- Oncolytics Biotech Inc. is withdrawing ten previously filed Form F-10 Registration Statements, ranging from initial filings in 2007 to 2024.
- The withdrawal pertains to the unsold portion of securities that were registered under these statements.
- The deregistration covers various types of securities, including Units, Common Shares, subscription receipts, warrants, and debt securities.
- The post-effective amendments are scheduled to become effective on April 7, 2026, at 10:00 p.m. Eastern time.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative action, cleaning up old registration statements without indicating any positive or negative operational or financial developments.
Future Outlook
NA
Industry Context
StockSavvy.ai notes this is an administrative cleanup typical for companies that have previously registered securities for potential offerings but did not fully utilize those registrations. It does not directly reflect on current industry trends but rather on internal capital management practices.
Stakeholder Impact
- Shareholders: This is an administrative cleanup of old registration statements and does not indicate any immediate impact on the company's share count or capital structure from these specific filings.
Next Steps
- The post-effective amendments will become effective on April 7, 2026, at 10:00 p.m. Eastern time.
Key Dates
| Date | Description |
|---|---|
| February 2, 2007 | Initial filing of Registration Statement No. 333-140460 |
| February 8, 2007 | Initial filing of Registration Statement No. 333-140529 |
| June 6, 2008 | Initial filing of Registration Statement No. 333-151513 |
| June 2, 2010 | Initial filing of Registration Statement No. 333-167250 |
| June 21, 2012 | Initial filing of Registration Statement No. 333-182260 |
| July 25, 2014 | Initial filing of Registration Statement No. 333-197633 |
| April 25, 2018 | Initial filing of Registration Statement No. 333-224432 |
| June 8, 2020 | Initial filing of Registration Statement No. 333-239025 |
| June 10, 2022 | Initial filing of Registration Statement No. 333-265510 |
| July 25, 2024 | Initial filing of Registration Statement No. 333-281009 |
| March 31, 2026 | Date of signing the post-effective amendments by Oncolytics Biotech Inc. |
| April 7, 2026 | Effective date of the post-effective amendments for deregistration |
Recommendation
holdThis filing is an administrative update to deregister unsold securities from old registration statements. It does not provide new financial or operational data that would warrant a change in investment recommendation.
Keywords
Oncolytics Biotech, SEC filing, F-10POS, deregistration, securities withdrawal, common shares, units, debt securities, capital markets
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.